An acute internal jugular, subclavian, or axillary DVT is a relatively ... with an internal jugular vein thrombosis being the most common source. The inconsistent use of anticoagulation therapy ...

Glucotrack (GCTK) reports successful completion of first human clinical study for continuous blood glucose monitoring, shares ...

The company’s system is placed in the subclavian vein, a blood vessel that runs under the collar bone bringing deoxygenated ...

Glucotrack has cleared the first human clinical study of its long-term continuous glucose monitoring implant, designed to ...

Three to four percent of cases of TOS are due to obstruction or clotting of the main vein to the arm - the subclavian vein - a condition called venous TOS. Venous TOS is commonly due to strenuous use ...

The femoral, jugular, subclavian, and cubital veins are the most frequently used sites for CVC insertion in children. In newborns, cubital veins and the saphenous vein are also frequently used for ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

RUTHERFORD, N.J. - Glucotrack, Inc. (NASDAQ: GCTK), a medical technology company, announced the successful completion of its first in human clinical study for a novel continuous glucose monitoring ...

Glucotrack (Nasdaq:GCTK) announced today that it completed the first-in-human clinical study of its continuous blood glucose ...

Glucotrack (GCTK) announced the successful completion of its first in human clinical study, marking a significant milestone in continuous ...

This study represents the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein, offering the potential for direct blood glucose measurement without the limitations ...

The company’s system is placed in the subclavian vein, a blood vessel that runs under the collar bone bringing deoxygenated blood back to the heart. Glucotrack calls its device, which has no ...